Alex Fries
Advisor Investment Fund @ Energie360°
Saratoga, United States
Alex Fries is a seed investor at Energie360° in Saratoga focused on FinTech and Software. Mr. Fries founded Ecosystem Ventures in December of 2005 to address the pending need for investment and support in European technologies and pre-seed-stage companies. Mr. Fries began his career as a telecommunications analyst for Credit Suisse, and went on to build and prepare MCI WorldCom in Switzerland for the European telecommunicationsliberalization.Mr. Fries then moved on to work as Executive Vice President of sales and marketing for Advance Visual Communications, a Boston-based venture-backed content company sold to USWeb, and as a senior market manager for Europe and Latin America at the Lucent Technologies Wireless Broadband Division.Mr. Fries brings over 20 years of progressive experience in founding, funding, and managing global businesses that provide technology, products, and services to telecommunication operators, enterprises, and consumers. His most recent entrepreneurial experiences include the co-founding of Playspan Inc (e-commerce & mirco-payment platform for online gaming) and sold to VISA International in 2011 , SDK Biotechnologies Inc. (Diagnostics) and PURE SWISS AG (Beverage brand). In 2001 Mr. Fries also co-founded the ETH spin-off SVOX AG, a venture-backed company in Switzerland, where he led the marketing, business development, and strategic partnerships teams and sold to Nuance Communications Inc in 2011.Mr. Fries is founder of the European-American Angels Club, a Silicon Valley-based organization that actively invests in European Start-ups. He also heads the Club Entrepreneur, a sub-chapter of the Swiss-American Chamber of Commerce in Northern California, where he is also a member of the Board of Directors. In 2010, Mr. Fries was also appointed to the Board of the Social Entrepreneurship Initiative, the first of its kind in Switzerland.Mr. Fries received a BA in finance and an M.B.A. in telecommunications and international marketing from the University of San Francisco. Prior to moving to the United States, Mr. Fries accomplished a Swiss Banking Diploma at UBS. He has lived in Hong-Kong, Switzerland, Chile, and the USA, and speaks fluent German, Spanish, French, and English. This background allows Mr. Fries to interact professionally in a multilingual, multicultural business environment.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Alex Fries invests in
Stages Alex Fries invests in
Countries Alex Fries invests in
Investment Focus
Industry
- FinTech 2 (17%)
- Software 2 (17%)
- Health Care 2 (17%)
- Financial Services 2 (17%)
- Apps 1 (8%)
Stage
- Seed 5 (42%)
- Series A 3 (25%)
- Angel 1 (8%)
- Convertible Note 1 (8%)
Country
- United States 5 (42%)
- Switzerland 2 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tinamu
|
Tinamu Labs has developed a technology that converts commercially available drones into camera equipment reaching professional standards. | $1.2M / Seed / Aug 25, 2020 | |
GYANT
|
GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise. | $13.6M / Series A / Jul 15, 2020 | |
|
GYANT
|
GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise. | $2.4M / Seed / Jun 14, 2019 | |
Stoovo
|
Stoovo's mission is to redefine how delivery companies operate, focusing on the crucial "last meter" that traditional systems ignore. | Seed / Jun 01, 2019 | |
Altoida
|
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt. | $6.3M / Series A / May 23, 2019 | |
|
GYANT
|
GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise. | $6.2M / Seed / Jun 06, 2018 | |
|
Altoida
|
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt. | $750K / Convertible Note / May 22, 2018 | |
Car IQ
|
Car IQ’s cutting-edge payments platform eliminates the credit card completely and connects your vehicle directly to merchants to make secure payments. Car IQ integrates with existing tech stacks and uses telematics and vehicle data to provide fleets with detailed vehicle insights, enabling them to monitor each transaction and prevent fraud. Car IQconsolidates all transactions into a single ledger, reducing reconciliation and enabling fleets to manage their spending more effectively. | $250K / Seed / Nov 01, 2017 | |
|
Altoida
|
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt. | $1.4M / Seed / Dec 16, 2016 | |
|
Altoida
|
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt. | $1.4M / Seed / Dec 16, 2016 | |
| See all 12 investments → | |||
Co-Investors
About Energie360°
One of Switzerland's largest gas distribution and energy services companies
Energie360° Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Joerg Wild
CEO
|
|||
|
Alex Fries
Advisor Investment Fund
|
|||
Felix Grolman
Head of Energy - Member of Executive Board
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alex Fries invest in?
Alex Fries invests primarily in FinTech, Software and Health Care startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Alex Fries last invest?
The most recent investment recorded for Alex Fries closed in Aug 2020. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
